Publications by authors named "Manfred Volm"

Claim this Profile
M
Multiple resistance to carcinogens and xenobiotics: P-glycoproteins as universal detoxifiers.
Thomas Efferth, Manfred Volm

Arch Toxicol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Cancer Drug Resistance and Implications for Personalized Medicine.
Manfred Volm, Thomas Efferth

Front Oncol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Could a revision of the current guidelines for cancer drug use improve the quality of cancer treatment?
Theodor H Lippert, Hans-Jörg Ruoff, Manfred Volm

Ther Clin Risk Manag· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current status of methods to assess cancer drug resistance.
Theodor H Lippert, Hans-Jörg Ruoff, Manfred Volm

Int J Med Sci· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients.
Alexei V Salnikov, Jury Gladkich, Gerhard Moldenhauer, Manfred Volm, Jürgen Mattern

Int J Cancer· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrinsic and acquired drug resistance in malignant tumors. The main reason for therapeutic failure.
Theodor H Lippert, Hans-Jörg Ruoff, Manfred Volm

Arzneimittelforschung· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance in malignant tumors: can resistance assays optimize cytostatic chemotherapy?
Theodor Hermann Lippert, Hans-Jörg Ruoff, Manfred Volm

Pharmacology· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of broad spectrum resistance of tumors towards anticancer drugs.
Thomas Efferth, V Badireenath Konkimalla, Yi-Fen Wang, Axel Sauerbrey, Silke Meinhardt, Manfred Volm

Clin Cancer Res· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glutathione-related enzymes contribute to resistance of tumor cells and low toxicity in normal organs to artesunate.
Thomas Efferth, Manfred Volm

In Vivo· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetics for individualized cancer chemotherapy.
Thomas Efferth, Manfred Volm

Pharmacol Ther· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imbalance of cell proliferation and apoptosis during progression of lung carcinomas.
Jürgen Mattern, Manfred Volm

Anticancer Res· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung Cancer Protein Expression Profiles of Smokers and Non-Smokers.
Thomas Efferth, Reet Koomägi, Jürgen Mattern, Manfred Volm

Cancer Genomics Proteomics· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Drug Sensitivity and Resistance of Cancer by Protein Expression Profiling.
Manfred Volm, Reet Koomagi, Thomas Efferth

Cancer Genomics Proteomics· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein Expression Profiles Indicative for Drug Resistance of Kidney Carcinoma.
Thomas Efferth, Manfred Volm

Cancer Genomics Proteomics· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular modes of action of artesunate in tumor cell lines.
Thomas Efferth, Axel Sauerbrey, Armin Olbrich, Erich Gebhart, Pia Rauch, Manfred Volm

Mol Pharmacol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular predictive factors of drug resistance in non-small cell lung carcinomas.
Manfred Volm, Reet Koomägi, Werner Rittgen

Methods Mol Med· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic relevance of angiogenic, proliferative, and apoptotic factors in lung carcinomas. A case review.
Manfred Volm, Reet Koomägi

Methods Mol Med· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of drug resistance gene products during progression of lung carcinomas.
Jürgen Mattern, Reet Koomägi, Manfred Volm

Oncol Rep· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of multidrug resistance in human ovarian cancer cell lines by inhibition of P-glycoprotein 170 and PKC isoenzymes with antisense oligonucleotides.
Ulrike Masanek, Gerd Stammler, Manfred Volm

J Exp Ther Oncol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein expression profiles of non-small cell lung carcinomas: correlation with histological subtype.
Manfred Volm, Reet Koomägi, Thomas Efferth, Jürgen Mattern

Anticancer Res· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein expression profile of primary human squamous cell lung carcinomas indicative of the incidence of metastases.
Manfred Volm, Reet Koomägi, Jürgen Mattern, Thomas Efferth

Clin Exp Metastasis· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of long-term survivors of untreated lung cancer.
Jürgen Mattern, Reet Koomägi, Manfred Volm

Lung Cancer· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression profile of genes in non-small cell lung carcinomas from long-term surviving patients.
Manfred Volm, Reet Koomägi, Jürgen Mattern, Thomas Efferth

Clin Cancer Res· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression profile of proteins involved in the xenotransplantability of non-small cell lung cancers into athymic nude mice.
Thomas Efferth, Reet Koomägi, Jürgen Mattern, Manfred Volm

Int J Oncol· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Effect of lithium and thiocyanate ions on the synthesis of nucleic acids and proteins inTetrahymena pyriformes GL].
Manfred Volm, Klaus Wayss, Viktor Schwartz

Wilhelm Roux Arch Entwickl Mech Org· June 1970

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis